Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Christina Ha, MD, of Cedars-Sinai in Los Angeles, California.
Conference Coverage
Unconventional Infusions: Considerations for Biosimilars and Home Infusions
12/10/2021
Christina Ha, MD, of Cedars-Sinai, presented on biosimilars and at-home infusions at the Advances in Inflammatory Bowel Disease 2021 Meeting.
Christina Ha, MD, of Cedars-Sinai, presented on biosimilars and at-home infusions at the Advances in Inflammatory Bowel Disease 2021 Meeting.
Christina Ha, MD, of...
12/10/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Gary Lichtenstein, MD
Conference Coverage
Gary Lichtenstein, MD, on Micronutrient Deficiencies in IBD
12/09/2021
Dr Lichtenstein discusses his presentation from Advances in Inflammatory Bowel Diseases 2021 on common deficiencies in micronutrients that may occur among patients with inflammatory bowel disease, and how best to treat them.
Dr Lichtenstein discusses his presentation from Advances in Inflammatory Bowel Diseases 2021 on common deficiencies in micronutrients that may occur among patients with inflammatory bowel disease, and how best to treat them.
Dr Lichtenstein discusses his...
12/09/2021
Advances in Inflammatory Bowel Disease Network
Laura Raffals, MD, of the Mayo Clinic in Rochester, Minnesota
Conference Coverage
A Review of Musculoskeletal Extraintestinal Manifestations of IBD
12/09/2021
At the Advances in Inflammatory Bowel Disease 2021 Meeting, Laura Raffals, MD, of the Mayo Clinic in Rochester, Minnesota, presented on musculoskeletal extraintestinal manifestations of inflammatory bowel diseases and the concerns related to...
At the Advances in Inflammatory Bowel Disease 2021 Meeting, Laura Raffals, MD, of the Mayo Clinic in Rochester, Minnesota, presented on musculoskeletal extraintestinal manifestations of inflammatory bowel diseases and the concerns related to...
At the Advances in Inflammatory...
12/09/2021
Advances in Inflammatory Bowel Disease Network
Alan Moss, MD
Conference Coverage
Alan Moss, MD, on Pulmonary Manifestations of IBD
12/09/2021
Dr Moss recapped his presentation at Advances in Inflammatory Bowel Diseases 2021 on monitoring for and addressing pulmonary issues among patients with IBD.  Alan Moss, MD, is a professor of medicine and director of Crohn's &...
Dr Moss recapped his presentation at Advances in Inflammatory Bowel Diseases 2021 on monitoring for and addressing pulmonary issues among patients with IBD.  Alan Moss, MD, is a professor of medicine and director of Crohn's &...
Dr Moss recapped his...
12/09/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Dr Edward Barnes
Video
Edward Barnes, MD, on Emerging Management of Disorders of the Pouch
11/23/2021
In this video, Dr Barnes discusses the highlights from his presentation on Emerging Management of Disorders of the Pouch from the Advances in Inflammatory Bowel Disease regional meeting on September 25.
In this video, Dr Barnes discusses the highlights from his presentation on Emerging Management of Disorders of the Pouch from the Advances in Inflammatory Bowel Disease regional meeting on September 25.
In this video, Dr Barnes...
11/23/2021
Advances in Inflammatory Bowel Disease Network
Aline Charabaty
Conference Coverage
Aline Charabaty, MD, on the Safety of Ustekinumab Among Older Patients With IBD
11/08/2021
Dr Charabaty, from Johns Hopkins School of Medicine, discusses the poster presentation on the study of safety of ustekinumab among patients aged 60 years and older with inflammatory disease, which was shown at the recent American College of...
Dr Charabaty, from Johns Hopkins School of Medicine, discusses the poster presentation on the study of safety of ustekinumab among patients aged 60 years and older with inflammatory disease, which was shown at the recent American College of...
Dr Charabaty, from Johns Hopkins...
11/08/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst
Conference Coverage
Sara Horst, MD, on the Impact of Insurance Delay on Dose Escalation of Subcutaneous Biologics in IBD
11/05/2021
Dr Horst, from Vanderbilt University, reviews the results a study of how a delay of more than 14 days in escalating dosage of biologic treatment can affect outcomes for patients with IBD.
Dr Horst, from Vanderbilt University, reviews the results a study of how a delay of more than 14 days in escalating dosage of biologic treatment can affect outcomes for patients with IBD.
Dr Horst, from Vanderbilt...
11/05/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

acg logo
Conference Coverage
Starting, Switching, and Stopping Therapy for IBD
11/04/2021
Dr Christina Ha, from Cedars-Sinai, moderated a discussion at the ACG Scientific Meeting with Dr Raymond Cross, from the University of Maryland, and Dr Bincy Abraham, from Houston Methodist, about beginning IBD therapy, changing therapeutic...
Dr Christina Ha, from Cedars-Sinai, moderated a discussion at the ACG Scientific Meeting with Dr Raymond Cross, from the University of Maryland, and Dr Bincy Abraham, from Houston Methodist, about beginning IBD therapy, changing therapeutic...
Dr Christina Ha, from...
11/04/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst
Conference Coverage
Sara Horst, MD, on Medication Adherence Among Patients Treated With Subcutaneous Biologics for IBD
11/03/2021
Dr Horst, from Vanderbilt University, discusses her research into differences in medication adherence among patients using subcutaneous biologics for IBD based on access to a specialty pharmacy.
Dr Horst, from Vanderbilt University, discusses her research into differences in medication adherence among patients using subcutaneous biologics for IBD based on access to a specialty pharmacy.
Dr Horst, from Vanderbilt...
11/03/2021
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky MD
Conference Coverage
Marla Dubinsky, MD, on Contraception and Preconception Counseling in IBD
10/24/2021
Dr Dubinsky, from the Icahn School of Medicine, discussed common fears women with inflammatory bowel disease express around contraception, fertility, and pregnancy, and how gastroenterologists can help to assuage them.
Dr Dubinsky, from the Icahn School of Medicine, discussed common fears women with inflammatory bowel disease express around contraception, fertility, and pregnancy, and how gastroenterologists can help to assuage them.
Dr Dubinsky, from the Icahn...
10/24/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use